We are live on ! Find out more

176 hedge funds and large institutions have $2.35B invested in Insmed in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 19

34% more capital invested

Capital invested by funds: $1.75B → $2.35B (+$601M)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

12% more funds holding

Funds holding: 157176 (+19)

0.95% less ownership

Funds ownership: 111.01%110.06% (-0.95%)

5% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 56

18% less call options, than puts

Call options by funds: $16.4M | Put options by funds: $20M

Holders
176
Holders Change
+19
Holders Change %
+12.1%
% of All Funds
3.47%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
38
Increased
53
Reduced
56
Closed
19
Calls
$16.4M
Puts
$20M
Net Calls
-$3.57M
Net Calls Change
+$3.94M

INSM Hedge Fund Activity: Q4 2019 in Review

176 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2019, worth a combined $2.35B — up 34% from $1.75B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INSM positions and 19 closed out — a net gain of 19 holders — while 53 added to existing stakes and 56 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $16.8M. The largest seller was Credit Suisse, cutting an estimated $12.6M.

  • 176 institutional investors held Insmed (INSM) as of Q4 2019, up from 157 in Q3 2019.
  • Funds reported $2.35B of Insmed stock for Q4 2019, up 34% quarter-over-quarter.
  • 38 funds opened new Insmed positions in Q4 2019 and 19 closed out, a net change of +19 holders.
  • The largest Insmed buyer in Q4 2019 was Millennium Management, an estimated $16.8M added.
  • The largest Insmed seller in Q4 2019 was Credit Suisse, an estimated $12.6M sold.

Based on aggregated 13F filings for Q4 2019.